We are representing a software company in ongoing litigation related to trade secret misappropriation, trademark claims, unfair competition, defamation, and various cyber-torts. Initially a competitor sued our client on these claims but during the discovery process it was revealed that the competitor actually was in violation of the claims. We obtained injunctive relief and Rule 11 Sanctions in the Northern District of Georgia against the competitor and the claims were dismissed as frivolous. After the dismissal, we countersued the competitor on similar grounds. The counter claim is currently ongoing.
Injunctive Relief for Software Company in Trademark Litigation
You Also May Be Interested In:
Lead Counsel to POINT Biopharma Inc. in its Proposed SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Represented Boston Children’s Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder
We represented Tractor Supply Company (Nasdaq: TSCO) in their agreement to acquire Orscheln Farm and Home, a family-owned farm and ranch retailer.